DW's individualized German language learning materials can help you to improve your skills with a host of fun and free materials for all levels. dw.com/germancourses We welcome posts in English and German. However, DW will delete and/or report any content that constitutes hateful, threatening, pornographic or harrassing material. Please respect our netiquette: http://bit.ly/b3Ui11 Legal Notice: http://www.dw.com/dw/article/0,,15718489,00.html
…
continue reading
Content provided by U2FP CureCast, Matthew Rodreick, and Jason Stoffer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by U2FP CureCast, Matthew Rodreick, and Jason Stoffer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
NervGen's Clinical Trial (Episode 92)
MP3•Episode home
Manage episode 390455055 series 2393962
Content provided by U2FP CureCast, Matthew Rodreick, and Jason Stoffer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by U2FP CureCast, Matthew Rodreick, and Jason Stoffer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today’s conversation is a highly anticipated one. For years we’ve been hearing about the groundbreaking work of Jerry Silver to render the injury scar permeable to axon growth. That work led to development of the pharmacologic NVG-291 and the associated company NervGen Pharma. The research has finally advanced to a human SCI clinical trial, led by Monica Perez, PT, PhD, who's today's guest. Dr. Perez is the scientific chair of the Arm and Hands Lab at Shirley Ryan AbilityLab and a Professor of Physical Medicine and Rehabilitation at Northwestern University in Chicago. In this conversation we talk about what led Monica into SCI research, her role as Principal Investigator in this clinical trial, the background and study design of the trial and its current recruitment of participants. More info: https://u2fp.org/get-educated/curecast/episode-92.html
…
continue reading
109 episodes
MP3•Episode home
Manage episode 390455055 series 2393962
Content provided by U2FP CureCast, Matthew Rodreick, and Jason Stoffer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by U2FP CureCast, Matthew Rodreick, and Jason Stoffer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today’s conversation is a highly anticipated one. For years we’ve been hearing about the groundbreaking work of Jerry Silver to render the injury scar permeable to axon growth. That work led to development of the pharmacologic NVG-291 and the associated company NervGen Pharma. The research has finally advanced to a human SCI clinical trial, led by Monica Perez, PT, PhD, who's today's guest. Dr. Perez is the scientific chair of the Arm and Hands Lab at Shirley Ryan AbilityLab and a Professor of Physical Medicine and Rehabilitation at Northwestern University in Chicago. In this conversation we talk about what led Monica into SCI research, her role as Principal Investigator in this clinical trial, the background and study design of the trial and its current recruitment of participants. More info: https://u2fp.org/get-educated/curecast/episode-92.html
…
continue reading
109 episodes
Wszystkie odcinki
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.